Vicapsys Life Sciences, Inc.
VICP
$1.77
$0.5039.37%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -24.78% | -37.33% | -26.12% | -20.03% | -81.16% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -75.08% |
| Total Amortization of Deferred Charges | 60.22% | 10,000.00% | -- | -- | -- |
| Total Other Non-Cash Items | -79.60% | -76.47% | -81.46% | -95.36% | 846.31% |
| Change in Net Operating Assets | 308.94% | 257.38% | 59.78% | 133.37% | 62.20% |
| Cash from Operations | 62.21% | 27.64% | -215.43% | -75.31% | 8.73% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -63.31% | -122.71% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -75.47% | 173.60% | 173.60% | -39.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 252.83% | 436.67% | 436.67% | 436.67% | -- |
| Cash from Financing | -55.07% | -108.04% | 1,079.43% | 1,079.43% | 59.96% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.23% | -208.09% | 95.78% | 97.69% | 119.58% |